Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer
PHASE4CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Study Completion Date
April 30, 2004
Conditions
AnemiaBreast CancerFatigue
Interventions
BIOLOGICAL
epoetin alfa
PROCEDURE
quality-of-life assessment
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00022386 - Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer | Biotech Hunter | Biotech Hunter